Abstract
CORRIGENDUM
Corrigendum to Manuscript entitled Cytotoxic Effects and Production of Cytokines Induced by the Endophytic Paenibacillus polymyxa RNC-D In Vitro by Débora M. Neris1,3,*, Genoveva L.F. Luna2,3, Joice M. de Almeida Rodolpho1,3, Ana C. Urbaczek4, Ricardo de Oliveira Correia3, Karina A. Feitosa1,3, Nadja F.G. Serrano2,3, Cristina P. de Sousa2,3 and Fernanda de Freitas Anibal1,2,3. Curr. Pharm. Biotechnol., 2017; 18(9), 758-768.
I hereby informed that all the authors agree with the inclusion of the name of the funding agency (FAPESP - Fundação de Amparo à Pesquisa do Estado de São Paulo) and the process number (2018/12846-5) to the acknowledgements section of the manuscript.
Current Pharmaceutical Biotechnology
Title:Erratum to Cytotoxic Effects and Production of Cytokines Induced by the Endophytic Paenibacillus polymyxa RNC-D In Vitro
Volume: 19 Issue: 14
Author(s):
Affiliation:
Abstract: CORRIGENDUM
Corrigendum to Manuscript entitled Cytotoxic Effects and Production of Cytokines Induced by the Endophytic Paenibacillus polymyxa RNC-D In Vitro by Débora M. Neris1,3,*, Genoveva L.F. Luna2,3, Joice M. de Almeida Rodolpho1,3, Ana C. Urbaczek4, Ricardo de Oliveira Correia3, Karina A. Feitosa1,3, Nadja F.G. Serrano2,3, Cristina P. de Sousa2,3 and Fernanda de Freitas Anibal1,2,3. Curr. Pharm. Biotechnol., 2017; 18(9), 758-768.
I hereby informed that all the authors agree with the inclusion of the name of the funding agency (FAPESP - Fundação de Amparo à Pesquisa do Estado de São Paulo) and the process number (2018/12846-5) to the acknowledgements section of the manuscript.
Export Options
About this article
Cite this article as:
, Erratum to Cytotoxic Effects and Production of Cytokines Induced by the Endophytic Paenibacillus polymyxa RNC-D In Vitro, Current Pharmaceutical Biotechnology 2018; 19 (14) . https://dx.doi.org/10.2174/138920101914190111105915
DOI https://dx.doi.org/10.2174/138920101914190111105915 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Advances and Future Directions in the Management of Metastatic Renal Cell Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Reduction of Oxidative/Nitrosative Stress in Brain and its Involvement in the Neuroprotective Effect of n-3 PUFA in Alzheimer’s Disease
Current Alzheimer Research The Immunomodulatory Potential of Selected Bioactive Plant-Based Compounds in Breast Cancer: A Review
Anti-Cancer Agents in Medicinal Chemistry Integrating Qualitative and Quantitative Tools for the Detection and Identification of Lectins in Major Human Diseases
Protein & Peptide Letters Multifunctional Materials for Cancer Therapy: From Antitumoral Agents to Innovative Administration
Current Organic Chemistry Gene Expression Meta-Analysis of Potential Metastatic Breast Cancer Markers
Current Molecular Medicine A Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab) in the Therapy of Moderate-to-Severe Allergic Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Piperidin-4-one: The Potential Pharmacophore
Mini-Reviews in Medicinal Chemistry Exosome Limitations in the Treatment of Inflammatory Diseases
Current Pharmaceutical Design Targeting the Tumor Proteasome as a Mechanism to Control the Synthesis and Bioactivity of Matrix Macromolecules
Current Molecular Medicine Subject Index To Volume 5
Anti-Infective Agents in Medicinal Chemistry Editorial [Hot Topic:Anti-Inflammatory Strategy: Old Ally or New Promise in Therapy (Guest Editor: Marcella Reale)]
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Inhibitors of AP-1 and NF-κB Mediated Transcriptional Activation: Therapeutic Potential in Autoimmune Diseases and Structural Diversity
Current Medicinal Chemistry Side Effects of AAS Abuse: An Overview
Mini-Reviews in Medicinal Chemistry The ATP-driven Hsp60 Machinery: Biological and Clinical Implications
Current Immunology Reviews (Discontinued) Another Brick in the Wall: Innate Lymphoid Cells of the Intestine
Current Immunology Reviews (Discontinued) Preface
Current Topics in Medicinal Chemistry Telmisartan in the Management of Diabetic Nephropathy: A Contemporary View
Current Diabetes Reviews Action of Nanoparticles on Platelet Activation and Plasmatic Coagulation
Current Medicinal Chemistry Development of Microemulsion and Niosome Based Transdermal Formulations of Diclofenac Sodium and Comparative <I>In Vitro</i> and <i>Ex Vivo</i> Evaluations with Marketed Products
Drug Delivery Letters